Caina Technology Co

Caina Technology Co OCF Margin

The Operating Cash Flow Margin of Caina Technology Co (301122.SZ) as of Nov 19, 2026 is 5.23 %. In the previous year, Operating Cash Flow Margin was 27.18 % — a change of -80.76% (lower).

OCF Margin

5.23 %

YoY

-80.76%

Last updated:

Operating Cash Flow Margin of Caina Technology Co is 2025 5.23 % . Operating Cash Flow Margin of Caina Technology Co was 2024 27.18 % . It decreases by -80.76% lower compared to the previous year.

The Caina Technology Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
14.88 CNY
Jan 1, 2019
31.83 CNY
Jan 1, 2020
33.67 CNY
Jan 1, 2021
36.21 CNY
Jan 1, 2022
29.84 CNY
Jan 1, 2023
21.21 CNY
Jan 1, 2024
27.18 CNY
Jan 1, 2025
5.23 CNY
The Caina Technology Co OCF Margin history
YEAROCF MarginYoY
5.23 %-80.76%
27.18 %+28.18%
21.21 %-28.92%
29.84 %-17.60%
36.21 %+7.54%
33.67 %+5.78%
31.83 %+113.91%
14.88 %+3,292.74%
0.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Operating Cash Flow Margin of Caina Technology Co is 5.23 % in 2025.

Operating Cash Flow Margin of Caina Technology Co changed from 27.18 % to 5.23 %, representing a -80.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Caina Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Caina Technology Co

All Key Metrics — Caina Technology Co